 Danielle Cooke
Concepts (485)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Arteriovenous Malformations | 26 | 2022 | 52 | 6.110 |
Why?
| | Embolization, Therapeutic | 28 | 2023 | 210 | 5.680 |
Why?
| | Intracranial Aneurysm | 20 | 2022 | 95 | 5.480 |
Why?
| | Endovascular Procedures | 22 | 2022 | 308 | 4.190 |
Why?
| | Central Nervous System Vascular Malformations | 12 | 2025 | 25 | 2.380 |
Why?
| | Subarachnoid Hemorrhage | 10 | 2022 | 62 | 2.380 |
Why?
| | Endothelial Cells | 8 | 2022 | 736 | 2.340 |
Why?
| | Cerebral Angiography | 24 | 2024 | 111 | 2.340 |
Why?
| | Stents | 11 | 2022 | 520 | 2.110 |
Why?
| | Stroke | 19 | 2023 | 1111 | 2.070 |
Why?
| | Biopsy | 7 | 2022 | 1098 | 2.050 |
Why?
| | Angiography, Digital Subtraction | 17 | 2025 | 45 | 1.930 |
Why?
| | Aneurysm, Ruptured | 7 | 2022 | 35 | 1.840 |
Why?
| | Arteriovenous Fistula | 8 | 2025 | 37 | 1.760 |
Why?
| | Tomography, X-Ray Computed | 18 | 2022 | 2539 | 1.500 |
Why?
| | Robotics | 3 | 2024 | 88 | 1.490 |
Why?
| | Brain Ischemia | 10 | 2022 | 308 | 1.220 |
Why?
| | Intracranial Hemorrhages | 7 | 2022 | 80 | 1.210 |
Why?
| | Basilar Artery | 2 | 2018 | 7 | 1.180 |
Why?
| | Retinoblastoma | 5 | 2023 | 31 | 1.140 |
Why?
| | Retinal Neoplasms | 4 | 2018 | 27 | 1.080 |
Why?
| | Vasospasm, Intracranial | 6 | 2017 | 17 | 1.080 |
Why?
| | Fluoroscopy | 8 | 2018 | 167 | 1.080 |
Why?
| | Feasibility Studies | 6 | 2022 | 876 | 1.040 |
Why?
| | Neurosurgery | 2 | 2022 | 34 | 0.930 |
Why?
| | Iliac Artery | 2 | 2014 | 56 | 0.890 |
Why?
| | Humans | 141 | 2025 | 129705 | 0.890 |
Why?
| | Magnetic Resonance Imaging | 20 | 2025 | 3351 | 0.880 |
Why?
| | Phantoms, Imaging | 6 | 2018 | 139 | 0.870 |
Why?
| | Radiography, Interventional | 5 | 2023 | 114 | 0.860 |
Why?
| | Magnetic Resonance Imaging, Interventional | 6 | 2016 | 23 | 0.850 |
Why?
| | Vascular Malformations | 5 | 2022 | 51 | 0.830 |
Why?
| | Radiosurgery | 8 | 2022 | 316 | 0.830 |
Why?
| | Thrombectomy | 8 | 2022 | 58 | 0.820 |
Why?
| | Endothelium, Vascular | 3 | 2019 | 920 | 0.820 |
Why?
| | Cerebral Hemorrhage | 7 | 2022 | 108 | 0.810 |
Why?
| | Software | 4 | 2020 | 611 | 0.810 |
Why?
| | Stroke Rehabilitation | 1 | 2023 | 40 | 0.810 |
Why?
| | Aneurysm | 3 | 2021 | 31 | 0.810 |
Why?
| | Retrospective Studies | 55 | 2025 | 14669 | 0.780 |
Why?
| | Brain | 16 | 2025 | 2596 | 0.760 |
Why?
| | Middle Aged | 58 | 2025 | 31103 | 0.740 |
Why?
| | Carotid Stenosis | 1 | 2022 | 86 | 0.730 |
Why?
| | Cerebral Arteries | 4 | 2017 | 60 | 0.720 |
Why?
| | Male | 79 | 2025 | 63544 | 0.710 |
Why?
| | Magnetic Resonance Angiography | 6 | 2020 | 237 | 0.710 |
Why?
| | Neuroimaging | 6 | 2025 | 273 | 0.690 |
Why?
| | Balloon Occlusion | 1 | 2020 | 38 | 0.680 |
Why?
| | Central Nervous System Diseases | 1 | 2021 | 68 | 0.680 |
Why?
| | Veins | 3 | 2022 | 60 | 0.680 |
Why?
| | Vascular Access Devices | 3 | 2018 | 26 | 0.670 |
Why?
| | Carotid Artery, Common | 1 | 2020 | 37 | 0.660 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 108 | 0.660 |
Why?
| | Cerebral Veins | 3 | 2021 | 16 | 0.660 |
Why?
| | Treatment Outcome | 33 | 2023 | 10299 | 0.640 |
Why?
| | Melphalan | 3 | 2018 | 30 | 0.640 |
Why?
| | Catheterization, Peripheral | 3 | 2016 | 104 | 0.630 |
Why?
| | Needles | 2 | 2018 | 57 | 0.620 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 16 | 0.610 |
Why?
| | Graft Occlusion, Vascular | 1 | 2018 | 39 | 0.600 |
Why?
| | Wounds, Stab | 1 | 2018 | 12 | 0.600 |
Why?
| | Female | 77 | 2025 | 68561 | 0.590 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 453 | 0.590 |
Why?
| | Aged | 45 | 2025 | 22113 | 0.580 |
Why?
| | Jugular Veins | 1 | 2018 | 39 | 0.580 |
Why?
| | Neck Injuries | 1 | 2018 | 21 | 0.580 |
Why?
| | Nerve Net | 5 | 2020 | 249 | 0.570 |
Why?
| | Aorta, Thoracic | 1 | 2020 | 260 | 0.560 |
Why?
| | Obsessive-Compulsive Disorder | 3 | 2023 | 42 | 0.560 |
Why?
| | Lymphatic Abnormalities | 3 | 2022 | 19 | 0.550 |
Why?
| | Adult | 47 | 2025 | 35595 | 0.510 |
Why?
| | Angioplasty | 3 | 2022 | 47 | 0.500 |
Why?
| | Orbital Diseases | 2 | 2018 | 27 | 0.490 |
Why?
| | Vertebrobasilar Insufficiency | 1 | 2015 | 8 | 0.490 |
Why?
| | Disease Management | 3 | 2017 | 596 | 0.480 |
Why?
| | Renal Dialysis | 1 | 2018 | 417 | 0.460 |
Why?
| | Tissue and Organ Harvesting | 1 | 2015 | 75 | 0.460 |
Why?
| | Spinal Cord | 4 | 2025 | 362 | 0.450 |
Why?
| | Magnetic Fields | 2 | 2014 | 22 | 0.450 |
Why?
| | Neural Pathways | 4 | 2020 | 290 | 0.450 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2020 | 253 | 0.440 |
Why?
| | Deep Brain Stimulation | 1 | 2015 | 96 | 0.430 |
Why?
| | Mammary Arteries | 1 | 2012 | 7 | 0.400 |
Why?
| | Cell Separation | 1 | 2013 | 313 | 0.400 |
Why?
| | Transcranial Magnetic Stimulation | 3 | 2020 | 55 | 0.400 |
Why?
| | Infusions, Intra-Arterial | 6 | 2018 | 54 | 0.400 |
Why?
| | Brain Neoplasms | 2 | 2025 | 1137 | 0.400 |
Why?
| | Infarction, Middle Cerebral Artery | 2 | 2013 | 36 | 0.400 |
Why?
| | Clinical Protocols | 3 | 2018 | 259 | 0.400 |
Why?
| | Vertebral Artery Dissection | 1 | 2012 | 24 | 0.400 |
Why?
| | Blood Vessel Prosthesis | 3 | 2019 | 126 | 0.390 |
Why?
| | Catheters | 4 | 2017 | 68 | 0.380 |
Why?
| | Sclerotherapy | 4 | 2022 | 18 | 0.380 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 3 | 2021 | 264 | 0.370 |
Why?
| | Radial Artery | 2 | 2021 | 68 | 0.360 |
Why?
| | Temporal Arteries | 1 | 2011 | 47 | 0.360 |
Why?
| | Atherosclerosis | 1 | 2015 | 392 | 0.360 |
Why?
| | Carotid Artery, Internal | 4 | 2019 | 41 | 0.350 |
Why?
| | Transcriptome | 3 | 2022 | 872 | 0.350 |
Why?
| | Neuronavigation | 1 | 2010 | 7 | 0.340 |
Why?
| | Ultrasonography, Doppler, Transcranial | 4 | 2017 | 40 | 0.340 |
Why?
| | Surgical Instruments | 1 | 2010 | 53 | 0.340 |
Why?
| | Arteriovenous Malformations | 2 | 2020 | 29 | 0.330 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 305 | 0.320 |
Why?
| | Carotid-Cavernous Sinus Fistula | 2 | 2019 | 8 | 0.320 |
Why?
| | Cardiac Catheterization | 1 | 2013 | 583 | 0.310 |
Why?
| | Cerebrovascular Circulation | 5 | 2022 | 224 | 0.310 |
Why?
| | Connectome | 5 | 2020 | 83 | 0.300 |
Why?
| | Magnetics | 4 | 2016 | 44 | 0.300 |
Why?
| | Vasodilator Agents | 1 | 2010 | 325 | 0.300 |
Why?
| | Ophthalmic Artery | 2 | 2018 | 5 | 0.300 |
Why?
| | Foramen Magnum | 2 | 2021 | 10 | 0.300 |
Why?
| | Contrast Media | 4 | 2020 | 388 | 0.290 |
Why?
| | Aged, 80 and over | 12 | 2022 | 7074 | 0.290 |
Why?
| | Brain Mapping | 5 | 2020 | 562 | 0.290 |
Why?
| | Cerebral Revascularization | 2 | 2020 | 18 | 0.280 |
Why?
| | Cohort Studies | 11 | 2023 | 5410 | 0.250 |
Why?
| | Antineoplastic Agents, Alkylating | 2 | 2018 | 70 | 0.250 |
Why?
| | Sclerosing Solutions | 3 | 2022 | 9 | 0.250 |
Why?
| | Child | 25 | 2023 | 20963 | 0.250 |
Why?
| | Preoperative Care | 3 | 2021 | 345 | 0.250 |
Why?
| | Young Adult | 16 | 2025 | 12363 | 0.250 |
Why?
| | Meningioma | 2 | 2016 | 78 | 0.240 |
Why?
| | Embolectomy | 2 | 2017 | 14 | 0.240 |
Why?
| | Cervical Vertebrae | 2 | 2025 | 132 | 0.240 |
Why?
| | Risk Factors | 9 | 2022 | 9832 | 0.240 |
Why?
| | Catheterization | 2 | 2017 | 177 | 0.240 |
Why?
| | Intracranial Arteriosclerosis | 2 | 2014 | 8 | 0.230 |
Why?
| | Adolescent | 23 | 2025 | 20355 | 0.230 |
Why?
| | Infant | 13 | 2023 | 9097 | 0.230 |
Why?
| | Mutation | 5 | 2021 | 3674 | 0.230 |
Why?
| | Perfusion Imaging | 3 | 2022 | 57 | 0.220 |
Why?
| | Mosaicism | 2 | 2021 | 71 | 0.220 |
Why?
| | Microsurgery | 2 | 2021 | 68 | 0.220 |
Why?
| | Imaging, Three-Dimensional | 3 | 2020 | 559 | 0.220 |
Why?
| | Radiography | 4 | 2014 | 863 | 0.220 |
Why?
| | Computed Tomography Angiography | 3 | 2020 | 117 | 0.210 |
Why?
| | Swine | 6 | 2018 | 744 | 0.210 |
Why?
| | Implosive Therapy | 1 | 2023 | 44 | 0.210 |
Why?
| | Radiology, Interventional | 1 | 2023 | 31 | 0.200 |
Why?
| | Neurosurgical Procedures | 5 | 2022 | 168 | 0.200 |
Why?
| | Cerebral Cortex | 3 | 2022 | 407 | 0.200 |
Why?
| | Machine Learning | 2 | 2024 | 419 | 0.200 |
Why?
| | Child, Preschool | 15 | 2021 | 10565 | 0.200 |
Why?
| | Flow Cytometry | 2 | 2017 | 1151 | 0.200 |
Why?
| | Ventriculostomy | 2 | 2013 | 22 | 0.190 |
Why?
| | Giant Cell Arteritis | 1 | 2022 | 50 | 0.190 |
Why?
| | Polyarteritis Nodosa | 1 | 2021 | 6 | 0.190 |
Why?
| | Methamphetamine | 1 | 2022 | 57 | 0.190 |
Why?
| | Hematoma | 1 | 2021 | 55 | 0.190 |
Why?
| | Actins | 2 | 2013 | 403 | 0.190 |
Why?
| | Materials Testing | 2 | 2020 | 343 | 0.190 |
Why?
| | Cerebrovascular Disorders | 1 | 2022 | 91 | 0.180 |
Why?
| | Precision Medicine | 1 | 2025 | 385 | 0.180 |
Why?
| | Combined Modality Therapy | 3 | 2016 | 1213 | 0.180 |
Why?
| | Angioplasty, Balloon | 1 | 2022 | 90 | 0.180 |
Why?
| | Iodine Compounds | 1 | 2020 | 3 | 0.180 |
Why?
| | Surgery, Computer-Assisted | 2 | 2019 | 76 | 0.180 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 30 | 0.180 |
Why?
| | Equipment Design | 5 | 2015 | 527 | 0.180 |
Why?
| | Gene Expression | 2 | 2017 | 1477 | 0.180 |
Why?
| | Moyamoya Disease | 1 | 2020 | 18 | 0.180 |
Why?
| | Brain Infarction | 1 | 2020 | 22 | 0.180 |
Why?
| | Calcium Channel Blockers | 2 | 2022 | 126 | 0.180 |
Why?
| | Orbit | 2 | 2011 | 56 | 0.180 |
Why?
| | Growth Disorders | 1 | 2021 | 79 | 0.180 |
Why?
| | Phenotype | 5 | 2021 | 3063 | 0.170 |
Why?
| | Observer Variation | 2 | 2020 | 321 | 0.170 |
Why?
| | Nervous System Diseases | 2 | 2021 | 261 | 0.170 |
Why?
| | Recurrence | 3 | 2020 | 1016 | 0.170 |
Why?
| | Spinal Cord Diseases | 1 | 2020 | 40 | 0.170 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2011 | 78 | 0.170 |
Why?
| | Telangiectasia, Hereditary Hemorrhagic | 1 | 2020 | 13 | 0.170 |
Why?
| | Blood Vessels | 1 | 2022 | 184 | 0.170 |
Why?
| | Head Injuries, Penetrating | 1 | 2020 | 5 | 0.170 |
Why?
| | Models, Anatomic | 1 | 2020 | 94 | 0.170 |
Why?
| | Unconsciousness | 1 | 2020 | 20 | 0.170 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1507 | 0.170 |
Why?
| | Drug Administration Schedule | 1 | 2022 | 763 | 0.170 |
Why?
| | Printing, Three-Dimensional | 1 | 2020 | 81 | 0.170 |
Why?
| | Mental Health Services | 1 | 2024 | 398 | 0.170 |
Why?
| | Pyrimidinones | 1 | 2020 | 102 | 0.170 |
Why?
| | Mental Health | 2 | 2024 | 676 | 0.160 |
Why?
| | Follow-Up Studies | 9 | 2021 | 4939 | 0.160 |
Why?
| | Torticollis | 1 | 2019 | 12 | 0.160 |
Why?
| | Amnesia | 1 | 2019 | 42 | 0.160 |
Why?
| | Polyvinyls | 2 | 2016 | 19 | 0.160 |
Why?
| | Brain Stem | 1 | 2020 | 95 | 0.160 |
Why?
| | Cerebral Infarction | 2 | 2022 | 42 | 0.160 |
Why?
| | Pitch Perception | 1 | 2019 | 9 | 0.160 |
Why?
| | Behavioral Symptoms | 1 | 2019 | 41 | 0.160 |
Why?
| | Dimethyl Sulfoxide | 2 | 2016 | 41 | 0.160 |
Why?
| | Electrocardiography | 3 | 1998 | 607 | 0.160 |
Why?
| | Models, Neurological | 1 | 2021 | 233 | 0.160 |
Why?
| | Reproducibility of Results | 6 | 2020 | 3054 | 0.160 |
Why?
| | Blood Flow Velocity | 2 | 2017 | 414 | 0.160 |
Why?
| | Pyridones | 1 | 2020 | 158 | 0.160 |
Why?
| | Postoperative Hemorrhage | 1 | 2019 | 85 | 0.160 |
Why?
| | Aspirin | 1 | 2022 | 379 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2020 | 91 | 0.150 |
Why?
| | Rabbits | 2 | 2022 | 758 | 0.150 |
Why?
| | Vascular Patency | 1 | 2018 | 102 | 0.150 |
Why?
| | Blood-Brain Barrier | 1 | 2019 | 128 | 0.150 |
Why?
| | Family Health | 1 | 2019 | 199 | 0.150 |
Why?
| | Plaque, Atherosclerotic | 1 | 2019 | 49 | 0.150 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2019 | 530 | 0.150 |
Why?
| | Cell Count | 1 | 2019 | 317 | 0.150 |
Why?
| | Retinal Vein | 1 | 2018 | 12 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 242 | 0.150 |
Why?
| | Receptor, TIE-1 | 1 | 2017 | 1 | 0.150 |
Why?
| | Diagnosis, Differential | 3 | 2017 | 1442 | 0.150 |
Why?
| | Endoglin | 1 | 2017 | 20 | 0.140 |
Why?
| | Motivation | 1 | 2022 | 542 | 0.140 |
Why?
| | Memory | 1 | 2019 | 231 | 0.140 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2017 | 55 | 0.140 |
Why?
| | von Willebrand Factor | 1 | 2017 | 59 | 0.140 |
Why?
| | Gyrus Cinguli | 1 | 2017 | 78 | 0.140 |
Why?
| | Phlebography | 1 | 2017 | 36 | 0.140 |
Why?
| | Diagnostic Errors | 1 | 2018 | 163 | 0.140 |
Why?
| | Cochlear Implantation | 1 | 2019 | 86 | 0.140 |
Why?
| | Depression | 3 | 2022 | 1290 | 0.140 |
Why?
| | Cochlear Implants | 1 | 2019 | 103 | 0.140 |
Why?
| | Radiographic Image Enhancement | 1 | 2017 | 58 | 0.140 |
Why?
| | Infant, Newborn | 8 | 2023 | 5752 | 0.140 |
Why?
| | Retinal Diseases | 1 | 2018 | 86 | 0.140 |
Why?
| | Conscious Sedation | 1 | 2017 | 84 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2017 | 94 | 0.140 |
Why?
| | Microvessels | 1 | 2017 | 79 | 0.130 |
Why?
| | Thalamus | 1 | 2017 | 79 | 0.130 |
Why?
| | Workflow | 1 | 2017 | 149 | 0.130 |
Why?
| | Prospective Studies | 9 | 2021 | 7130 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 504 | 0.130 |
Why?
| | Health Care Costs | 1 | 2019 | 405 | 0.130 |
Why?
| | Depressive Disorder | 1 | 2019 | 361 | 0.130 |
Why?
| | Quality Improvement | 1 | 2024 | 1113 | 0.130 |
Why?
| | Meningeal Arteries | 1 | 2015 | 2 | 0.130 |
Why?
| | Tantalum | 1 | 2015 | 3 | 0.130 |
Why?
| | Ferrous Compounds | 1 | 2015 | 23 | 0.130 |
Why?
| | Renal Artery | 1 | 2016 | 33 | 0.130 |
Why?
| | Time-to-Treatment | 1 | 2017 | 182 | 0.130 |
Why?
| | Carotid Arteries | 1 | 2017 | 207 | 0.130 |
Why?
| | Magnets | 1 | 2015 | 19 | 0.130 |
Why?
| | Hematoma, Subdural, Intracranial | 1 | 2015 | 1 | 0.130 |
Why?
| | Telemedicine | 1 | 2024 | 792 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 2039 | 0.130 |
Why?
| | Filtration | 1 | 2015 | 63 | 0.120 |
Why?
| | Meningeal Neoplasms | 1 | 2016 | 89 | 0.120 |
Why?
| | American Heart Association | 1 | 2017 | 311 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1696 | 0.120 |
Why?
| | Ferric Compounds | 1 | 2015 | 45 | 0.120 |
Why?
| | Time Factors | 3 | 2022 | 6593 | 0.120 |
Why?
| | Hearing Loss | 1 | 2019 | 208 | 0.120 |
Why?
| | Aneurysm, False | 1 | 2015 | 46 | 0.120 |
Why?
| | Genotype | 1 | 2020 | 1836 | 0.120 |
Why?
| | Hemodynamics | 2 | 2017 | 1097 | 0.120 |
Why?
| | Collateral Circulation | 1 | 2015 | 19 | 0.120 |
Why?
| | Laser Capture Microdissection | 1 | 2014 | 23 | 0.120 |
Why?
| | Biopsy, Needle | 1 | 2015 | 192 | 0.120 |
Why?
| | Myocardial Infarction | 3 | 1998 | 1032 | 0.120 |
Why?
| | Drug Carriers | 1 | 2015 | 115 | 0.120 |
Why?
| | Intracranial Hypertension | 1 | 2015 | 38 | 0.120 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 124 | 0.120 |
Why?
| | Lasers | 1 | 2015 | 132 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2017 | 293 | 0.120 |
Why?
| | Decision Making | 2 | 2021 | 842 | 0.120 |
Why?
| | Vein of Galen Malformations | 1 | 2014 | 3 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 870 | 0.110 |
Why?
| | DNA, Complementary | 1 | 2014 | 271 | 0.110 |
Why?
| | Magnetic Phenomena | 1 | 2014 | 11 | 0.110 |
Why?
| | Depressive Disorder, Major | 1 | 2017 | 347 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2783 | 0.110 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 328 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2013 | 44 | 0.110 |
Why?
| | Reference Values | 1 | 2015 | 792 | 0.110 |
Why?
| | Recovery of Function | 1 | 2018 | 643 | 0.110 |
Why?
| | Optical Imaging | 1 | 2014 | 56 | 0.110 |
Why?
| | Prognosis | 7 | 2017 | 3801 | 0.110 |
Why?
| | Artifacts | 1 | 2014 | 124 | 0.110 |
Why?
| | Tungsten | 1 | 2013 | 30 | 0.110 |
Why?
| | Equipment Failure Analysis | 1 | 2013 | 132 | 0.110 |
Why?
| | Skin | 2 | 2017 | 737 | 0.100 |
Why?
| | Alloys | 1 | 2013 | 35 | 0.100 |
Why?
| | Ketones | 1 | 2013 | 47 | 0.100 |
Why?
| | Neck | 2 | 2023 | 92 | 0.100 |
Why?
| | Intracranial Thrombosis | 1 | 2012 | 17 | 0.100 |
Why?
| | Radiation Dosage | 1 | 2014 | 159 | 0.100 |
Why?
| | Animals | 9 | 2022 | 34733 | 0.100 |
Why?
| | Comorbidity | 2 | 2014 | 1545 | 0.100 |
Why?
| | Carboxypeptidases | 1 | 1992 | 13 | 0.100 |
Why?
| | Paresis | 1 | 2012 | 30 | 0.100 |
Why?
| | Aorta, Abdominal | 1 | 2012 | 45 | 0.100 |
Why?
| | Zygoma | 1 | 2011 | 11 | 0.090 |
Why?
| | Proteoglycans | 1 | 1992 | 108 | 0.090 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 1981 | 0.090 |
Why?
| | Serine Endopeptidases | 1 | 1992 | 113 | 0.090 |
Why?
| | Cranial Sinuses | 2 | 2021 | 12 | 0.090 |
Why?
| | Peptide Hydrolases | 1 | 1992 | 109 | 0.090 |
Why?
| | Cells, Cultured | 2 | 2022 | 4058 | 0.090 |
Why?
| | Health Personnel | 1 | 2017 | 645 | 0.090 |
Why?
| | Ethanol | 1 | 2015 | 578 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 185 | 0.090 |
Why?
| | Mast Cells | 1 | 1992 | 142 | 0.090 |
Why?
| | Parents | 1 | 2019 | 1311 | 0.090 |
Why?
| | Hot Temperature | 1 | 2013 | 363 | 0.090 |
Why?
| | Cell Survival | 1 | 2013 | 1083 | 0.090 |
Why?
| | Cerebral Ventriculography | 1 | 2010 | 3 | 0.090 |
Why?
| | Angiography | 3 | 2018 | 201 | 0.090 |
Why?
| | Echoencephalography | 1 | 2010 | 4 | 0.090 |
Why?
| | Organotechnetium Compounds | 1 | 2010 | 10 | 0.090 |
Why?
| | Cerebral Ventricles | 1 | 2010 | 48 | 0.080 |
Why?
| | Quality of Life | 1 | 2022 | 2712 | 0.080 |
Why?
| | Spinal Neoplasms | 1 | 2009 | 29 | 0.080 |
Why?
| | Anxiety Disorders | 2 | 2023 | 349 | 0.080 |
Why?
| | Datasets as Topic | 2 | 2020 | 108 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2024 | 525 | 0.080 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2022 | 431 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2522 | 0.080 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 1849 | 0.080 |
Why?
| | Hydrocephalus | 1 | 2010 | 104 | 0.080 |
Why?
| | Cysteine | 1 | 2010 | 191 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2019 | 739 | 0.080 |
Why?
| | Emergency Medical Services | 1 | 1996 | 645 | 0.080 |
Why?
| | RNA | 1 | 2014 | 877 | 0.070 |
Why?
| | ROC Curve | 2 | 2022 | 503 | 0.070 |
Why?
| | Rupture | 2 | 2020 | 101 | 0.070 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 230 | 0.070 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 598 | 0.070 |
Why?
| | Arteries | 2 | 2022 | 268 | 0.070 |
Why?
| | Brain Injuries | 1 | 2013 | 471 | 0.070 |
Why?
| | Electronic Health Records | 2 | 2024 | 969 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2019 | 3363 | 0.070 |
Why?
| | Registries | 1 | 2015 | 2008 | 0.070 |
Why?
| | Injections, Intra-Arterial | 2 | 2015 | 25 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2015 | 4016 | 0.060 |
Why?
| | Anxiety | 2 | 2023 | 949 | 0.060 |
Why?
| | Atlases as Topic | 1 | 2025 | 10 | 0.060 |
Why?
| | Regional Blood Flow | 2 | 2018 | 463 | 0.060 |
Why?
| | Patient Health Questionnaire | 1 | 2024 | 34 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 5396 | 0.060 |
Why?
| | Age Distribution | 2 | 2014 | 380 | 0.060 |
Why?
| | Camping | 1 | 2023 | 6 | 0.050 |
Why?
| | Phobic Disorders | 1 | 2023 | 29 | 0.050 |
Why?
| | Models, Animal | 2 | 2016 | 370 | 0.050 |
Why?
| | Hypertension | 1 | 2012 | 1240 | 0.050 |
Why?
| | Physician's Role | 1 | 2024 | 202 | 0.050 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5050 | 0.050 |
Why?
| | Doxycycline | 1 | 2022 | 60 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 26 | 0.050 |
Why?
| | Head | 1 | 2022 | 96 | 0.050 |
Why?
| | Technology | 1 | 2022 | 85 | 0.050 |
Why?
| | Psychiatry | 1 | 2024 | 180 | 0.050 |
Why?
| | Age Factors | 2 | 2021 | 3145 | 0.050 |
Why?
| | Sodium | 1 | 2022 | 204 | 0.050 |
Why?
| | Mood Disorders | 1 | 2022 | 120 | 0.050 |
Why?
| | Skin Abnormalities | 1 | 2021 | 10 | 0.050 |
Why?
| | Aging, Premature | 1 | 2021 | 13 | 0.050 |
Why?
| | Intraoperative Period | 1 | 2021 | 53 | 0.050 |
Why?
| | Delayed Diagnosis | 1 | 2021 | 81 | 0.040 |
Why?
| | Intention | 1 | 2022 | 160 | 0.040 |
Why?
| | Survival Rate | 2 | 2014 | 1894 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2021 | 173 | 0.040 |
Why?
| | Vietnam Conflict | 1 | 2020 | 3 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2021 | 140 | 0.040 |
Why?
| | Headache | 1 | 2021 | 138 | 0.040 |
Why?
| | Canada | 1 | 2021 | 355 | 0.040 |
Why?
| | Models, Theoretical | 2 | 2014 | 551 | 0.040 |
Why?
| | Coma | 1 | 2020 | 32 | 0.040 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 9 | 0.040 |
Why?
| | Propensity Score | 1 | 2021 | 263 | 0.040 |
Why?
| | Age of Onset | 1 | 2021 | 494 | 0.040 |
Why?
| | Syndrome | 1 | 2020 | 343 | 0.040 |
Why?
| | Defense Mechanisms | 1 | 2019 | 24 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 265 | 0.040 |
Why?
| | Corneal Edema | 1 | 1999 | 3 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 1999 | 14 | 0.040 |
Why?
| | Fibroblasts | 2 | 2022 | 946 | 0.040 |
Why?
| | Gray Matter | 1 | 2020 | 79 | 0.040 |
Why?
| | Visual Cortex | 1 | 2020 | 67 | 0.040 |
Why?
| | Refractive Errors | 1 | 1999 | 18 | 0.040 |
Why?
| | Endothelium, Corneal | 1 | 1999 | 15 | 0.040 |
Why?
| | Diplopia | 1 | 2019 | 17 | 0.040 |
Why?
| | Basal Ganglia | 1 | 2019 | 51 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2019 | 211 | 0.040 |
Why?
| | Monocytes | 1 | 2022 | 554 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2019 | 42 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 64 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2020 | 482 | 0.040 |
Why?
| | Thiophenes | 1 | 1999 | 118 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1047 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2019 | 127 | 0.040 |
Why?
| | Problem Behavior | 1 | 2019 | 90 | 0.040 |
Why?
| | Polytetrafluoroethylene | 1 | 1998 | 25 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 1998 | 19 | 0.040 |
Why?
| | Paracentesis | 1 | 2018 | 11 | 0.040 |
Why?
| | Coronary Care Units | 1 | 1998 | 16 | 0.040 |
Why?
| | Postoperative Complications | 2 | 2021 | 2500 | 0.040 |
Why?
| | Anterior Cerebral Artery | 1 | 2017 | 5 | 0.040 |
Why?
| | Groin | 1 | 2017 | 13 | 0.040 |
Why?
| | Punctures | 1 | 2017 | 40 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 201 | 0.040 |
Why?
| | Middle Cerebral Artery | 1 | 2017 | 45 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 484 | 0.040 |
Why?
| | Speech Perception | 1 | 2019 | 81 | 0.040 |
Why?
| | Drug Delivery Systems | 1 | 2020 | 328 | 0.040 |
Why?
| | Hemorrhage | 1 | 2022 | 697 | 0.040 |
Why?
| | Cerebellum | 1 | 2019 | 216 | 0.040 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.030 |
Why?
| | Carotid Artery, External | 1 | 2016 | 3 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 140 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2021 | 706 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2019 | 254 | 0.030 |
Why?
| | Blood Volume | 1 | 2016 | 61 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2051 | 0.030 |
Why?
| | United States | 3 | 2021 | 14078 | 0.030 |
Why?
| | Genetic Variation | 1 | 2021 | 936 | 0.030 |
Why?
| | Gray Platelet Syndrome | 1 | 2015 | 3 | 0.030 |
Why?
| | Mental Disorders | 1 | 2024 | 1025 | 0.030 |
Why?
| | Fibrous Dysplasia, Polyostotic | 1 | 2015 | 7 | 0.030 |
Why?
| | Venous Pressure | 1 | 2015 | 9 | 0.030 |
Why?
| | Dexamethasone | 1 | 2018 | 331 | 0.030 |
Why?
| | Image Enhancement | 1 | 2016 | 165 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2670 | 0.030 |
Why?
| | Drug Compounding | 1 | 2015 | 97 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 380 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1996 | 319 | 0.030 |
Why?
| | Sulfonamides | 1 | 1999 | 494 | 0.030 |
Why?
| | Sex Distribution | 1 | 1996 | 361 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 118 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2015 | 193 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2557 | 0.030 |
Why?
| | Particle Size | 1 | 2015 | 348 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2015 | 308 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1406 | 0.030 |
Why?
| | Perfusion | 1 | 2015 | 191 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 394 | 0.030 |
Why?
| | Multimodal Imaging | 1 | 2015 | 107 | 0.030 |
Why?
| | Mydriasis | 1 | 2013 | 9 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1008 | 0.030 |
Why?
| | Causality | 1 | 2014 | 114 | 0.030 |
Why?
| | Electromagnetic Radiation | 1 | 2013 | 2 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2019 | 510 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1526 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2014 | 296 | 0.030 |
Why?
| | Benzophenones | 1 | 2013 | 16 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2018 | 573 | 0.030 |
Why?
| | Analysis of Variance | 1 | 1996 | 1288 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2112 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 281 | 0.030 |
Why?
| | Oxygen | 1 | 2017 | 921 | 0.030 |
Why?
| | California | 1 | 2014 | 403 | 0.030 |
Why?
| | Chymases | 1 | 1992 | 4 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 2272 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1992 | 83 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 1992 | 124 | 0.020 |
Why?
| | Molecular Weight | 1 | 1992 | 334 | 0.020 |
Why?
| | Exocytosis | 1 | 1992 | 89 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2705 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1567 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 6273 | 0.020 |
Why?
| | Blood Loss, Surgical | 1 | 2009 | 91 | 0.020 |
Why?
| | Polymers | 1 | 2013 | 475 | 0.020 |
Why?
| | Veterans | 1 | 2020 | 1398 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4863 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2612 | 0.020 |
Why?
| | Carcinoma, Renal Cell | 1 | 2009 | 181 | 0.020 |
Why?
| | Incidence | 1 | 2014 | 2658 | 0.020 |
Why?
| | Databases, Factual | 1 | 2012 | 1297 | 0.020 |
Why?
| | Kidney Neoplasms | 1 | 2009 | 352 | 0.020 |
Why?
| | Keratoplasty, Penetrating | 1 | 1999 | 4 | 0.010 |
Why?
| | Administration, Topical | 1 | 1999 | 148 | 0.010 |
Why?
| | Ophthalmic Solutions | 1 | 1999 | 74 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 175 | 0.010 |
Why?
| | Swine, Miniature | 1 | 1998 | 76 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 112 | 0.010 |
Why?
| | Electrodes | 1 | 1998 | 103 | 0.010 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 1998 | 152 | 0.010 |
Why?
| | Surface Properties | 1 | 1998 | 391 | 0.010 |
Why?
| | Visual Acuity | 1 | 1999 | 315 | 0.010 |
Why?
| | Intraocular Pressure | 1 | 1999 | 295 | 0.010 |
Why?
| | Lymphocytes | 1 | 1998 | 369 | 0.010 |
Why?
| | Glaucoma | 1 | 1999 | 217 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 264 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 1998 | 292 | 0.010 |
Why?
| | Heart Ventricles | 1 | 1998 | 779 | 0.010 |
Why?
| | Neutrophils | 1 | 1998 | 1205 | 0.010 |
Why?
|
|
Cooke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|